---
source_path: R2503C-PDF-ENG.md
pages: n/a-n/a
chunk_id: b51cc9e555910c9093c6e6cdf75eef16b0406ec4
title: R2503C-PDF-ENG
---
## key metrics for each of Amgen’s therapeutics, geographies, and

functions. If a business area is underperforming, the executive who

owns it presents the variance, identiﬁes its cause, and proposes a

Copyright © 2025 Harvard Business School Publishing. All rights reserved.

13

This document is authorized for use only by Matt O'Donnell (matthew.od11@gmail.com). Copying or posting is an infringement of copyright. Please contact customerservice@harvardbusiness.org or 800-988-0886 for additional copies.
